DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lingvay I, Desouza CV, Lalic KS. et al.
A 26-week randomized controlled trial of semaglutide once daily versus liraglutide and placebo in patients with type 2 diabetes suboptimally controlled on diet and exercise with or without metformin.
Diabetes Care 2018;
41 (09) 1926-1937
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.